MLLT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.499980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.572800E-01
Normal-vs-Stage2
1.208440E-01
Normal-vs-Stage3
4.726800E-01
Normal-vs-Stage4
8.346800E-01
Stage1-vs-Stage2
7.033200E-01
Stage1-vs-Stage3
3.976800E-01
Stage1-vs-Stage4
7.997800E-01
Stage2-vs-Stage3
4.607800E-01
Stage2-vs-Stage4
5.981800E-01
Stage3-vs-Stage4
4.404200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.362790E-01
Normal-vs-AfricanAmerican
7.331800E-01
Normal-vs-Asian
9.952000E-01
Caucasian-vs-AfricanAmerican
9.063000E-01
Caucasian-vs-Asian
5.926000E-01
AfricanAmerican-vs-Asian
8.125200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.651790E-01
Normal-vs-Female
3.255800E-01
Male-vs-Female
7.683600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.143550E-01
Normal-vs-Age(41-60Yrs)
7.008600E-01
Normal-vs-Age(61-80Yrs)
1.545940E-02
Normal-vs-Age(81-100Yrs)
7.543400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.308800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.523780E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.085600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.419900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.008000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.764370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.465240E-01
Normal-vs-Daily Drinker
1.771020E-01
Normal-vs-Weekly Drinker
1.453590E-01
Normal-vs-Occasional Drinker
3.638400E-01
Normal-vs-Social Drinker
9.820600E-01
Non Drinker-vs-Daily Drinker
9.032600E-01
Non Drinker-vs-Weekly Drinker
3.008100E-02
Non Drinker-vs-Occasional Drinker
7.752000E-01
Non Drinker-vs-Social Drinker
3.498200E-01
Daily Drinker-vs-Weekly Drinker
3.100300E-02
Daily Drinker-vs-Occasional Drinker
8.528400E-01
Daily Drinker-vs-Social Drinker
3.682200E-01
Weekly Drinker-vs-Occasional Drinker
6.830400E-02
Weekly Drinker-vs-Social Drinker
2.044200E-01
Occasional Drinker-vs-Social Drinker
5.152600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.363200E-01
Normal-vs-Grade 2
9.818200E-01
Normal-vs-Grade 3
9.784000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.788800E-01
Grade 1-vs-Grade 3
4.145400E-01
Grade 1-vs-Grade 4
9.363200E-01
Grade 2-vs-Grade 3
9.219200E-01
Grade 2-vs-Grade 4
9.818200E-01
Grade 3-vs-Grade 4
9.784000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.219700E-02
Normal-vs-NonDiabetic
5.513400E-01
Diabetic-vs-NonDiabetic
1.904810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.971600E-01
Normal-vs-NoPancreatitis
1.106960E-01
Pancreatitis-vs-NoPancreatitis
1.343020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.556000E-01
Normal-vs-N1
1.552030E-01
N0-vs-N1
9.057200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.886200E-02
Normal-vs-TP53-NonMutant
1.783610E-01
TP53-Mutant-vs-TP53-NonMutant
7.381400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
